• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments

cafead

Administrator
Staff member
  • cafead   May 06, 2024 at 06:12: PM
via Vertex Pharmaceuticals (VRTX.O) beat Wall Street estimates for first-quarter profit on Monday, driven by robust uptake for its cystic fibrosis treatments.

Cystic fibrosis (CF) - an inherited disorder that causes severe damage to the lungs, digestive system and other organs - affects an estimated 105,000 people across 94 countries, according to data from U.S.-based CF Foundation.

article source
 

<